- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.08. | Earnings Call: Treace Medical übertrifft Q2-Prognosen - Aktie springt um 24 % | - | Investing.com Deutsch | ||
| 07.08. | Treace Medical Concepts GAAP EPS of -$0.24 beats by $0.06, revenue of $45.4M beats by $1.48M | 2 | Seeking Alpha | ||
| 07.08. | TREACE MEDICAL CONCEPTS, INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 07.08. | Treace Medical Concepts, Inc.: Treace Medical Concepts Reports Second Quarter 2026 Financial Results | 450 | GlobeNewswire (Europe) | PONTE VEDRA, Fla., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
| TREACE MEDICAL CONCEPTS Aktie jetzt für 0€ handeln | |||||
| 07.08. | TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 24.07. | Treace Medical Concepts, Inc.: Treace to Report Second Quarter 2026 Financial Results on August 7, 2026 | 2 | GlobeNewswire (USA) | ||
| 18.06. | Treace Medical Concepts, Inc.: Treace Announces First Surgical Case with the HyperPlate XM Dynamic Compression Locking Implant System | 2 | GlobeNewswire (USA) | ||
| 20.05. | TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.05. | TREACE MEDICAL CONCEPTS, INC. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 08.05. | Treace Medical: Aktie steigt nach übertroffenen Quartalszahlen trotz Umsatzminus | 1 | Investing.com Deutsch | ||
| 08.05. | Treace Medical Concepts GAAP EPS of -$0.28 beats by $0.03, revenue of $47.2M beats by $1.15M | 3 | Seeking Alpha | ||
| 08.05. | Treace Medical Concepts, Inc.: Treace Medical Concepts Reports First Quarter 2026 Financial Results | 846 | GlobeNewswire (Europe) | PONTE VEDRA, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
| 08.05. | TREACE MEDICAL CONCEPTS, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 08.05. | TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 24.04. | Treace Medical Concepts, Inc.: Treace to Report First Quarter 2026 Financial Results on May 8, 2026 | 2 | GlobeNewswire (USA) | ||
| 09.04. | Stifel belässt Treace Medical auf 'Halten' mit Kursziel von 3 US-Dollar | 3 | Investing.com Deutsch | ||
| 09.04. | Stifel maintains Hold on Treace Medical stock, $3 target unchanged | 1 | Investing.com | ||
| 09.04. | TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 07.04. | Treace Medical Concepts, Inc.: Treace Announces First Surgical Cases with the SuperBite Compression Screw System | 356 | GlobeNewswire (Europe) | PONTE VEDRA, Fla., April 07, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
| 27.02. | Treace Medical Concepts, Inc.: Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results | 813 | GlobeNewswire (Europe) | PONTE VEDRA, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen |
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PICARD MEDICAL | 6,350 | +1,28 % | Picard Medical, Inc.: Picard Medical Reports Second Quarter 2026 Financial Results | - Revenue Increases 39% and Net Loss Decreases 16%- Year-to-Date Revenue Increases 50%, with ~$0.9 Million in Gross Profit TUCSON, Ariz., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE... ► Artikel lesen | |
| FRESENIUS | 45,245 | -1,01 % | EQS-DD: Fresenius SE & Co. KGaA: Michael Sen, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
08.09.2026 / 11:02... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 10,460 | -19,13 % | Alignment Healthcare USA, LLC: Alignment Health's Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen | ||
| FRESENIUS MEDICAL CARE | 39,790 | +0,58 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat FMC auf "Underweight" belassen. Die Experten Anchal Verma und David Adlington bleiben für die europäischen Medizintechnikunternehmen wegen des... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,240 | +0,64 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Siemens Healthineers auf "Overweight" belassen. Die Experten Anchal Verma und David Adlington bleiben für die europäischen Medizintechnikunternehmen... ► Artikel lesen | |
| TENON MEDICAL | 6,450 | +16,01 % | Tenon Medical Announces Closing of Warrant Inducement Offering for Aggregate Gross Proceeds of Approximately $2,872,338 | LOS GATOS, CA / ACCESS Newswire / September 14, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain... ► Artikel lesen | |
| HEARTFLOW | 48,590 | -1,92 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 30,220 | -0,20 % | 589 Millionen Menschen mit Diabetes: Warum die globale Diabetes-Welle zum Technologiethema für die Augen wird - und wo Rise Nano Optics ins Spiel kommt | ||
| BRIGHTSPRING HEALTH SERVICES | 59,24 | -1,76 % | BrightSpring Health Services auf Jefferies-Konferenz: Wachstum auf breiter Front | ||
| GERRESHEIMER | 27,580 | +0,29 % | JPMORGAN stuft GERRESHEIMER AG auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Gerresheimer auf "Overweight" belassen. Die Experten Anchal Verma und David Adlington bleiben für die europäischen Medizintechnikunternehmen wegen... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES | 23,770 | -1,21 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results | KIRKLAND, Wash., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results... ► Artikel lesen | |
| BETA BIONICS | 17,620 | +5,32 % | Beta Bionics, Inc.: Beta Bionics Announces FDA Clearance of Mint, the Company's Transformative Patch Pump, and Unveils 3D Intelligence as its Next-Generation Insulin Dosing Algorithm | Mint features a new and innovative patch pump architecture Full Mint U.S. commercialization expected to begin in Q1 2027 Manufacturing capacity expected to produce at least 1.5 million disposable... ► Artikel lesen | |
| GENEDX | 91,09 | +1,50 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| BILLIONTOONE | 102,90 | +2,10 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| OTTOBOCK | 54,00 | -2,35 % | EQS-PVR: Ottobock SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Ottobock SE & Co. KGaA
Ottobock SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
09.09.2026 / 13:39... ► Artikel lesen |
TREACE MEDICAL CONCEPTS INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 4,480 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu TREACE MEDICAL CONCEPTS INC finden Sie auf Wallstreet Online.